About Senzo
Senzo is a company based in San Francisco (United States) founded in 2013. Senzo has raised $9.6 million across 5 funding rounds from investors including HHS, Wellness Coaches and BioAdvance. The company has 13 employees as of January 31, 2022. Senzo operates in a competitive market with competitors including Souzhou Ribo Life Science, Hememics Biotechnologies, PathoQuest, Quantalife and Jieyi Biotechnology, among others.
- Headquarter San Francisco, United States
- Employees 13 as on 31 Jan, 2022
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Senzo Health Limited
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$9.6 M (USD)
in 5 rounds
-
Latest Funding Round
$1.8 M (USD), Seed
Oct 05, 2023
-
Investors
HHS
& 2 more
-
Employee Count
13
as on Jan 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Senzo
Senzo has successfully raised a total of $9.6M across 5 strategic funding rounds. The most recent funding activity was a Seed round of $1.8 million completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Senzo
Senzo has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, Wellness Coaches and BioAdvance.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Corporate health, wellness, and nutrition services are provided to businesses.
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for Senzo
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Senzo
Investment portfolio details for Senzo
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Senzo
Detailed financials for Senzo
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Senzo Comparisons
Peer comparison for Senzo
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Senzo
Senzo operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Souzhou Ribo Life Science, Hememics Biotechnologies, PathoQuest, Quantalife and Jieyi Biotechnology, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Nucleic acid drugs are developed via RNA interference technology.
|
|
| Locked | Locked | Locked |
Biopreservation platform for mammalian cells and biologics is developed.
|
|
| Locked | Locked | Locked |
Next-generation sequencing is provided for microbiology testing applications.
|
|
| Locked | Locked | Locked |
Provide tools that accelerate new strategies for the diagnosis and treatment of inherited disorders, cancer, and infectious disease.
|
|
| Locked | Locked | Locked |
Sequencing-based platform for microorganism detection in patients is developed.
|
Detailed competitors of Senzo
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Senzo
Complete news archive for Senzo
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Senzo
Senzo was founded in 2013 and raised its 1st funding round 9 years after it was founded.
Senzo is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Senzo is a funded company, having raised a total of $9.6M across 5 funding rounds to date.
As of Jan 31, 2022, the latest employee count at Senzo is 13.
The company was founded in 2013 in San Francisco, United States, within the health diagnostics sector. Portable rapid test devices are developed for detecting infectious diseases at the point of care. The Amplified Lateral Flow (ALF) device has been created as an alternative to PCR antigen tests. Diseases such as COVID-19, Flu AB, Tuberculosis, HIV, Hepatitis C, and C. difficile are targeted by these devices for on-site viral detection.
Senzo's top competitors include Souzhou Ribo Life Science, Quantalife and Hememics Biotechnologies.
Senzo has 3 investors. Key investors include HHS, Wellness Coaches, and BioAdvance.